Global Autologous CAR-T Cell Therapy Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Target: CD19
  • 1.2.3 Target: BCMA
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Autologous CAR-T Cell Therapy Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Hematological Tumors
  • 1.3.3 Solid Tumor
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Autologous CAR-T Cell Therapy Market Perspective (2019-2030)
• 2.2 Global Autologous CAR-T Cell Therapy Growth Trends by Region
  • 2.2.1 Global Autologous CAR-T Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Autologous CAR-T Cell Therapy Historic Market Size by Region (2019-2024)
  • 2.2.3 Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2025-2030)
• 2.3 Autologous CAR-T Cell Therapy Market Dynamics
  • 2.3.1 Autologous CAR-T Cell Therapy Industry Trends
  • 2.3.2 Autologous CAR-T Cell Therapy Market Drivers
  • 2.3.3 Autologous CAR-T Cell Therapy Market Challenges
  • 2.3.4 Autologous CAR-T Cell Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Autologous CAR-T Cell Therapy by Players
  • 3.1.1 Global Autologous CAR-T Cell Therapy Revenue by Players (2019-2024)
  • 3.1.2 Global Autologous CAR-T Cell Therapy Revenue Market Share by Players (2019-2024)
• 3.2 Global Autologous CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Autologous CAR-T Cell Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Autologous CAR-T Cell Therapy Market Concentration Ratio
  • 3.4.1 Global Autologous CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Autologous CAR-T Cell Therapy Revenue in 2023
• 3.5 Global Key Players of Autologous CAR-T Cell Therapy Head office and Area Served
• 3.6 Global Key Players of Autologous CAR-T Cell Therapy, Product and Application
• 3.7 Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Autologous CAR-T Cell Therapy Breakdown Data by Type

• 4.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Type (2019-2024)
• 4.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2025-2030)

5 Autologous CAR-T Cell Therapy Breakdown Data by Application

• 5.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Application (2019-2024)
• 5.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Autologous CAR-T Cell Therapy Market Size (2019-2030)
• 6.2 North America Autologous CAR-T Cell Therapy Market Size by Type
  • 6.2.1 North America Autologous CAR-T Cell Therapy Market Size by Type (2019-2024)
  • 6.2.2 North America Autologous CAR-T Cell Therapy Market Size by Type (2025-2030)
  • 6.2.3 North America Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)
• 6.3 North America Autologous CAR-T Cell Therapy Market Size by Application
  • 6.3.1 North America Autologous CAR-T Cell Therapy Market Size by Application (2019-2024)
  • 6.3.2 North America Autologous CAR-T Cell Therapy Market Size by Application (2025-2030)
  • 6.3.3 North America Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)
• 6.4 North America Autologous CAR-T Cell Therapy Market Size by Country
  • 6.4.1 North America Autologous CAR-T Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Autologous CAR-T Cell Therapy Market Size by Country (2019-2024)
  • 6.4.3 North America Autologous CAR-T Cell Therapy Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Autologous CAR-T Cell Therapy Market Size (2019-2030)
• 7.2 Europe Autologous CAR-T Cell Therapy Market Size by Type
  • 7.2.1 Europe Autologous CAR-T Cell Therapy Market Size by Type (2019-2024)
  • 7.2.2 Europe Autologous CAR-T Cell Therapy Market Size by Type (2025-2030)
  • 7.2.3 Europe Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)
• 7.3 Europe Autologous CAR-T Cell Therapy Market Size by Application
  • 7.3.1 Europe Autologous CAR-T Cell Therapy Market Size by Application (2019-2024)
  • 7.3.2 Europe Autologous CAR-T Cell Therapy Market Size by Application (2025-2030)
  • 7.3.3 Europe Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)
• 7.4 Europe Autologous CAR-T Cell Therapy Market Size by Country
  • 7.4.1 Europe Autologous CAR-T Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Autologous CAR-T Cell Therapy Market Size by Country (2019-2024)
  • 7.4.3 Europe Autologous CAR-T Cell Therapy Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Autologous CAR-T Cell Therapy Market Size (2019-2030)
• 8.2 China Autologous CAR-T Cell Therapy Market Size by Type
  • 8.2.1 China Autologous CAR-T Cell Therapy Market Size by Type (2019-2024)
  • 8.2.2 China Autologous CAR-T Cell Therapy Market Size by Type (2025-2030)
  • 8.2.3 China Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)
• 8.3 China Autologous CAR-T Cell Therapy Market Size by Application
  • 8.3.1 China Autologous CAR-T Cell Therapy Market Size by Application (2019-2024)
  • 8.3.2 China Autologous CAR-T Cell Therapy Market Size by Application (2025-2030)
  • 8.3.3 China Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Autologous CAR-T Cell Therapy Market Size (2019-2030)
• 9.2 Asia Autologous CAR-T Cell Therapy Market Size by Type
  • 9.2.1 Asia Autologous CAR-T Cell Therapy Market Size by Type (2019-2024)
  • 9.2.2 Asia Autologous CAR-T Cell Therapy Market Size by Type (2025-2030)
  • 9.2.3 Asia Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)
• 9.3 Asia Autologous CAR-T Cell Therapy Market Size by Application
  • 9.3.1 Asia Autologous CAR-T Cell Therapy Market Size by Application (2019-2024)
  • 9.3.2 Asia Autologous CAR-T Cell Therapy Market Size by Application (2025-2030)
  • 9.3.3 Asia Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)
• 9.4 Asia Autologous CAR-T Cell Therapy Market Size by Region
  • 9.4.1 Asia Autologous CAR-T Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Autologous CAR-T Cell Therapy Market Size by Region (2019-2024)
  • 9.4.3 Asia Autologous CAR-T Cell Therapy Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 JW (Cayman) Therapeutics
  • 11.1.1 JW (Cayman) Therapeutics Company Details
  • 11.1.2 JW (Cayman) Therapeutics Business Overview
  • 11.1.3 JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Introduction
  • 11.1.4 JW (Cayman) Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2019-2024)
  • 11.1.5 JW (Cayman) Therapeutics Recent Development
• 11.2 Gilead (Kite Pharma)
  • 11.2.1 Gilead (Kite Pharma) Company Details
  • 11.2.2 Gilead (Kite Pharma) Business Overview
  • 11.2.3 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Introduction
  • 11.2.4 Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2019-2024)
  • 11.2.5 Gilead (Kite Pharma) Recent Development
• 11.3 Bristol Myers Squibb
  • 11.3.1 Bristol Myers Squibb Company Details
  • 11.3.2 Bristol Myers Squibb Business Overview
  • 11.3.3 Bristol Myers Squibb Autologous CAR-T Cell Therapy Introduction
  • 11.3.4 Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2019-2024)
  • 11.3.5 Bristol Myers Squibb Recent Development
• 11.4 Novartis
  • 11.4.1 Novartis Company Details
  • 11.4.2 Novartis Business Overview
  • 11.4.3 Novartis Autologous CAR-T Cell Therapy Introduction
  • 11.4.4 Novartis Revenue in Autologous CAR-T Cell Therapy Business (2019-2024)
  • 11.4.5 Novartis Recent Development
• 11.5 Legend Biotech Corporation
  • 11.5.1 Legend Biotech Corporation Company Details
  • 11.5.2 Legend Biotech Corporation Business Overview
  • 11.5.3 Legend Biotech Corporation Autologous CAR-T Cell Therapy Introduction
  • 11.5.4 Legend Biotech Corporation Revenue in Autologous CAR-T Cell Therapy Business (2019-2024)
  • 11.5.5 Legend Biotech Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Target: CD19

Table 3. Key Players of Target: BCMA

Table 4. Key Players of Other

Table 5. Global Autologous CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Autologous CAR-T Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Autologous CAR-T Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Autologous CAR-T Cell Therapy Market Share by Region (2019-2024)

Table 9. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Autologous CAR-T Cell Therapy Market Share by Region (2025-2030)

Table 11. Autologous CAR-T Cell Therapy Market Trends

Table 12. Autologous CAR-T Cell Therapy Market Drivers

Table 13. Autologous CAR-T Cell Therapy Market Challenges

Table 14. Autologous CAR-T Cell Therapy Market Restraints

Table 15. Global Autologous CAR-T Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Autologous CAR-T Cell Therapy Market Share by Players (2019-2024)

Table 17. Global Top Autologous CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous CAR-T Cell Therapy as of 2023)

Table 18. Global Autologous CAR-T Cell Therapy Industry Ranking 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by Autologous CAR-T Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Autologous CAR-T Cell Therapy, Headquarters and Area Served

Table 21. Global Key Players of Autologous CAR-T Cell Therapy, Product and Application

Table 22. Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Autologous CAR-T Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Autologous CAR-T Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Autologous CAR-T Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Autologous CAR-T Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Autologous CAR-T Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Autologous CAR-T Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Autologous CAR-T Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Autologous CAR-T Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Autologous CAR-T Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Autologous CAR-T Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Autologous CAR-T Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Autologous CAR-T Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Autologous CAR-T Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Autologous CAR-T Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Autologous CAR-T Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Autologous CAR-T Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Autologous CAR-T Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Autologous CAR-T Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Autologous CAR-T Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Autologous CAR-T Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Autologous CAR-T Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Autologous CAR-T Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Autologous CAR-T Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Autologous CAR-T Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Autologous CAR-T Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Autologous CAR-T Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Autologous CAR-T Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 64. JW (Cayman) Therapeutics Company Details

Table 65. JW (Cayman) Therapeutics Business Overview

Table 66. JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Product

Table 67. JW (Cayman) Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2019-2024) & (US$ Million)

Table 68. JW (Cayman) Therapeutics Recent Development

Table 69. Gilead (Kite Pharma) Company Details

Table 70. Gilead (Kite Pharma) Business Overview

Table 71. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product

Table 72. Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2019-2024) & (US$ Million)

Table 73. Gilead (Kite Pharma) Recent Development

Table 74. Bristol Myers Squibb Company Details

Table 75. Bristol Myers Squibb Business Overview

Table 76. Bristol Myers Squibb Autologous CAR-T Cell Therapy Product

Table 77. Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2019-2024) & (US$ Million)

Table 78. Bristol Myers Squibb Recent Development

Table 79. Novartis Company Details

Table 80. Novartis Business Overview

Table 81. Novartis Autologous CAR-T Cell Therapy Product

Table 82. Novartis Revenue in Autologous CAR-T Cell Therapy Business (2019-2024) & (US$ Million)

Table 83. Novartis Recent Development

Table 84. Legend Biotech Corporation Company Details

Table 85. Legend Biotech Corporation Business Overview

Table 86. Legend Biotech Corporation Autologous CAR-T Cell Therapy Product

Table 87. Legend Biotech Corporation Revenue in Autologous CAR-T Cell Therapy Business (2019-2024) & (US$ Million)

Table 88. Legend Biotech Corporation Recent Development

Table 89. Research Programs/Design for This Report

Table 90. Key Data Information from Secondary Sources

Table 91. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Autologous CAR-T Cell Therapy Market Share by Type: 2023 VS 2030

Figure 3. Target: CD19 Features

Figure 4. Target: BCMA Features

Figure 5. Other Features

Figure 6. Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Autologous CAR-T Cell Therapy Market Share by Application: 2023 VS 2030

Figure 8. Hematological Tumors Case Studies

Figure 9. Solid Tumor Case Studies

Figure 10. Autologous CAR-T Cell Therapy Report Years Considered

Figure 11. Global Autologous CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Autologous CAR-T Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Autologous CAR-T Cell Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Autologous CAR-T Cell Therapy Market Share by Players in 2023

Figure 15. Global Top Autologous CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous CAR-T Cell Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Autologous CAR-T Cell Therapy Revenue in 2023

Figure 17. North America Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)

Figure 19. North America Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)

Figure 20. North America Autologous CAR-T Cell Therapy Market Share by Country (2019-2030)

Figure 21. United States Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)

Figure 25. Europe Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)

Figure 26. Europe Autologous CAR-T Cell Therapy Market Share by Country (2019-2030)

Figure 27. Germany Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)

Figure 35. China Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)

Figure 36. Asia Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)

Figure 38. Asia Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)

Figure 39. Asia Autologous CAR-T Cell Therapy Market Share by Region (2019-2030)

Figure 40. Japan Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Autologous CAR-T Cell Therapy Market Share by Country (2019-2030)

Figure 50. Brazil Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Autologous CAR-T Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. JW (Cayman) Therapeutics Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2019-2024)

Figure 57. Gilead (Kite Pharma) Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2019-2024)

Figure 58. Bristol Myers Squibb Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2019-2024)

Figure 59. Novartis Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2019-2024)

Figure 60. Legend Biotech Corporation Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed